Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| REGN | Regeneron Pharmaceuticals, Inc. | -1.28% | 569.28 | 2.7% | $666.01m | |
| ILMN | Illumina, Inc. | -0.29% | 319.51 | 3.5% | $656.56m | |
| AMGN | Amgen, Inc. | -1.22% | 228.28 | 1.3% | $591.90m | |
| ARRY | Array BioPharma Inc. | 3.53% | 39.86 | 14.2% | $519.90m | |
| GILD | Gilead Sciences, Inc. | -0.62% | 60.18 | 1.0% | $503.92m | |
| MRNA | Moderna, Inc. | -2.45% | 69.57 | 0.0% | $491.40m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -2.00% | 210.24 | 1.9% | $470.03m | |
| IMMU | Immunomedics, Inc. | 0.10% | 87.81 | 11.0% | $388.16m | |
| NVAX | Novavax, Inc. | -6.16% | 92.30 | 96.5% | $305.97m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -3.26% | 119.96 | 2.0% | $288.02m | |
| BIIB | Biogen, Inc. | -0.94% | 264.62 | 1.6% | $255.20m | |
| EXAS | EXACT Sciences Corp. | -2.27% | 100.69 | 20.7% | $224.15m | |
| BNTX | BioNTech SE | -6.89% | 87.85 | 0.0% | $209.91m | |
| SRNE | Sorrento Therapeutics, Inc. | -3.83% | 7.91 | 1.4% | $185.32m | |
| SGEN | Seagen Inc. | 0.53% | 199.07 | 6.0% | $170.99m |
Company Profile
Protagonist Therapeutics, Inc. engages in the research and development of novel constrained peptide-based drug candidates that address significant unmet medical needs. Its product pipeline include PTG-300, PTG-200, and PN-943 The company was founded by Mark L. Smythe on August 22, 2006 and is headquartered in Newark, CA.